He initiated chemotherapy (etoposide + lobaplatin + albumin paclitaxel) and immunotherapy (atezolizumab, a PD-L1 inhibitor) in June 2020 for one time and stopped due to poor physical condition and rapid tumor progression (Figure 3A). Here, CD274 is linked to neoplasm.